How Big Pharma misleads us: from painkillers to slimming pills
The maker of Nurofen has been censured for claims in its adverts. It’s not the only offender – there’s a whole body of overblown pharmaceutical ads
Your body is a temple under siege from advertisers lobbing promises of a smoother, leaner, healthier, less-likely-to-die-tomorrow you. But while you can go to town when touting a life-changing pair of trainers – or an unachievable vision for the future of a country – strict rules govern the advertising of pharmaceuticals. Go too far and there’s blowback from the Advertising Standards Authority (ASA), as Reckitt Benckiser, the firm that makes Nurofen, found out this week.
More From Around the Web
Check out these Articles
- Tabula Rasa HealthCare Subsidiary Medliance Promotes Rebstock to Executive ...
- Hard Brexit would mean patients waiting years for new drugs – report
- GlaxoSmithKline returning to health but China still bitter pill to swallow
- Martin Shkreli hires famous New York lawyer in Ponzi scheme case
- Shire clinches $32bn takeover of Baxalta
- Maker of broccoli-derived cancer drug to float on London stock exchange
- Acceliant to Participate in the 4th Annual Clinical Trials Summit in Mumbai
- A Lay Person’s Guide to the Hobby Lobby Decision
- Medicortex Finland Oy Receives an Innovation Grant for the Development of a...
- Cancer drug companies cut prices to win NHS approval
- Medcom Kinetics Launches New Web Presence
- BiologicsCorp Launches Supernatant Protein Expression Service